Index

A Berger, Johannes (Hans), 4, 21, 35, 36, 45 Actigraphy, 33–45, 254, 255 , 131, 165–180, 283 Adjuvant light therapy, 152 Biofeedback Certification International Adrian, Edgar Douglas, 21 Alliance (BCIA), 167 Adult attention deficit hyperactivity disorder Biosensor-monitoring techniques, 197 (ADHD), 41, 139, 155 Bipolar depression, 139, 145, 152–153 Advanced phase disorder (ASPD), 254 Bipolar I Disorder, 150 Advanced sleep phase type (ASPT), 153, 154 Bipolar II Disorder, 150 Aging, 24, 143, 246, 249, 251, 257, 270 Blood-oxygen-level-dependent (BOLD) fMRI, Alpha rhythm, 21 209 Alzheimer’s disease, 10, 11, 138, 254 Blood volume pulse (BVP), 171 American Academy of BMAL, 211 (AASM), 23, 24, 58, 59, 111, 112, 117, Body sensor networks (BSN), 274 154, 264, 265 Brief Screening Scale (BISS-C), 192, American Association of Sleep Disorders 193 (ASDA), 263, 264 Bright light therapy, 138, 145–155 Antepartum depression, 152 Bulimia nervosa, 139, 155 Antidepressant effect, 144–145, 149, 152 Burwell C. S., 25 Apnea/Hypopnea Index (AHI), 26, 58, 64, 91, Business model, 272, 273, 277, 280, 286 106, 107, 109–111, 113–117 Applied Psychophysiology and Biofeedback (AAPB), 166 C AR models, 10 Cardiovascular disorders, 57–58 Arousal system, 122, 123, 142, 143 Carskadon, Mary, 5, 26, 266 Aserinsky, Eugene, 5, 22 Caton, Richard, 20 Assessment, 9, 10, 33, 38–40, 78, 82, 114, 125, Cephalometry, 76 174, 187, 210, 245–257 Chronic depression, 152 ATP, 211 Circadian (Process C), 9 Autonomic nervous system (ANS), 124, 141, Circadian-related , 138 261 Circadian rhythm, 4, 5, 9, 10, 12, 33, 34, 38, Auto-titrating positive airway pressure 40, 43, 45, 123, 128, 131, 137–144, 148, (APAP), 60, 62–65 152–155, 186, 188, 253–254 Circadian rhythm sleep disorder (CRSD), 137, 139, 153–154, 253–254 B Circadian system, 122, 123, 125, 139, 186 Behavior therapy, 207 Clock, 122, 125, 137, 139–142, 152, 154, 188, Benzodiazepines, 44, 77, 250, 252 189, 196, 211, 254

R.P.-Y. Chiang and S.-C.J. Kang (eds.), Introduction to Modern Sleep Technology, 289 Intelligent Systems, Control and Automation: Science and Engineering 64, DOI 10.1007/978-94-007-5470-6, © Springer ScienceCBusiness Media Dordrecht 2012 290 Index

Coccagna, Giorgio, 25 Expiratory pressure relief devices, 51, 60, 64 Cognitive-behavioral therapy (CBT), 151, 191, Eye and mouth detection, 223 194, 250 Cognitive behavioral treatment for insomnia (CBT-I), 121–133, 190, 249, 250 F Complex /treatment emergent Face determination, 223, 224, 228–229 central sleep apnea, 60 Face model, 224–226, 228, 231 Continuous positive airway pressure (CPAP), Facial expression, 220, 235 5, 27, 29, 43, 51–65, 106, 112, 114–118, Facial feature detection and tracking, 221, 225, 251, 252 235, 236, 239, 240 Core body temperature, 142, 150, 154, 254 Facial parameter estimation, 225, 229–231, Core circadian genes, 211 236–238 C-reactive protein (CRP), 212 Feng-Shui, 8 Critical closing pressure (Pcrit), 55–56 First night effect, 34 Cry, 211 Five sleep stages (A, B, C, D and E), 21 Cycling alternating pattern (CAP), 265 Four stages of non-REM(1–3, and 4), 23 Free-running type, 153 Functional residual capacity (FRC), 55 D Fuzzy reasoning, 224, 225, 233–234 Davis, Hallowell and Pauline, 21 Delayed sleep phase type (DSPT), 153, 154 Delta, 10, 24, 171, 265 G Delta model, 278, 280–282, 284, 285 GABAergic, 138, 142 Dement, William Charles, 5, 22, 23, 26, 263 Galvani, Luigi (or Aloysio), 20 Dorsomedial hypothalamic nucleus (DMH), Gamma-aminobutyric acid (GABA), 140–143 138, 141–143 Gastaut, Henri, 25, 262 Dorsomedial SCN (SCNdm), 140, 141 General biofeedback, 167 Drachman, D.B., 25 Geniculo-hypothalamic tract (GHT), 140, 141 Driver vigilance monitoring system, 223 Geomantic omen, 8 Driving behavior, 220, 241 Gerardy, Werner, 25 Drowsiness monitoring, 234 Global sleep dissatisfaction (GSD), 187 DuBois-Reynold, Emil, 20 Glutamate, 138, 140, 141, 143 Duron, Bernard, 25 Glutamatergic pathway, 140 Dysfunctional thought, 129 Golgi, Camillo, 20 Guilleminault, Christian, 26, 262, 263 Gumnit R. J., 25

E EDA, 220 H EEG biofeedback, 167, 176, 180 Harvey, E. Newton, 4, 21 Electrocardiography (ECG), 201, 204–205 Heart rate variability (HRV), 6, 171, 175, 176, Electroencephalogram (EEG), 4, 21, 166, 171, 196, 197, 204 174, 179, 180, 201–203 Hobart III, Garret, 21 biofeedback, 171, Holland, Jerome, 26 179, 180 Homeostatic (Process S), 9 Electromyography (EMG), 166, 169–170, Homeostatic system, 122, 123 172–174, 178–180, 203–204 Horne-Ostberg¨ Morningness–Eveningness Electrooculogram (EOG), 22, 201, 205–206 Questionnaire, 148 Electrophysiological method, 205 Human serum albumin (HSA), 213 Empirically supported treatment (EST), 173 Hybrid analysis, 273, 278, 282, 286 Endoscopy, 73, 75 Hyperarousal, 123, 177 Engineering, 13, 179, 180, 190 , 144, 150, 247 Excessive daytime sleepiness (EDS), 25, 26, Hypnos, 20 29, 52, 65, 186, 251, 252 Hypnotic, 122, 128, 143, 250, 251, 256, 262 Index 291

I Lugaresi, Elio, 25, 262 Illuminance, 146, 147, 149 Lux, 138, 142–151, 154, 155 Indoor air quality (IAQ), 186 Industrial design, 13, 190 Infrared (IR), 221, 241 M Insomnia, 4, 8, 33–36, 38–40, 44, 45, 58, 62, Magnetic resonance imaging (MRI), 79, 208, 121–133, 143, 154, 165–180, 186, 187, 209 190–194, 199, 207, 246–250, 257, 262, Maintenance Wakefulness Test (MWT), 26, 266 29, 57 Insomniac, 193 Major depressive episode, 150, 155 Intensity, 9, 38, 109, 110, 132, 139, 142, 143, Management, 5, 6, 13, 41, 51–65, 71–100, 145–148, 152, 154, 186, 188, 189, 240 105–118, 121–133, 137–155, 165–180, Interdisciplinary cooperation, 4 245–257, 273, 281 International Society for Neurofeedback & Maxillomandibular advancement (MMA), 84, Research (ISNR), 167 91, 92, 95 Internet-based self-help CBT-I treatment, 132 Melatonin, 40, 43, 138, 139, 141–144, 148, Irregular sleep wake disorder (ISWD), 254 150, 151, 155, 250, 253, 254 Irregular sleep-wake phase type, 153 Monoamine hypothesis, 144 Monoamine oxidase inhibitors (MAOI), 144 Morpheus, 20 Movement disorder, 24, 34, 44, 247 J Multi-factorial geriatric syndrome, 246 , 138, 153, 154 Multiple sleep latency test (MSLT), 5, 26, 29, Jet lag type, 153 57 Johannes Berger, 4 Journal of Behavioral Medicine, 166 Jouvet, Michel Valentin Marcel, 23, 262 N Jung, R, 25 , 23, 263 Near-infrared (NIR), 82, 221, 241 Negative pressure upper airway reflex, 52–53 K Neurofeedback, 167, 172, 176–180 Kales, Anthony, 5, 23, 264 Neuropeptide pituitary adenylate cyclase- Kalman filter, 223 activating protein (PACAP), 140, Kleitman, Nathaniel, 5, 21–23 141 Krieger, Jean, 26 Neuropeptide Y (NPY), 140, 141 Kuhlo, W, 25 Noise, 6–8, 62, 64, 79, 155, 169, 170, 186, Kurtz, Daniel, 26 199, 203, 212, 255, 256 Non-REM sleep, 9, 21, 23, 110, 206, 207, 265 Non-seasonal depression, 138, 139, 147, 151–152 L Non-seasonal mood disorders, 138 Late luteal phase dysphoric disorder, 139 Number of nocturnal awakening (NWAK), 34, Lateral geniculate, 140 42 Light box, 146 Nursing home, 42, 43, 155, 255, 256 Light deprivation, 144 Nyx, 20 Light emitting diodes (LEDs), 149, 151, 171, 188, 220 Light therapy, 131–132, 137–155, 188, 249, O 254 Obesity-hypoventilation syndrome, 25 Light visor, 146 Objective measures, 26, 38, 45, 210 Linear discriminate function (LDF), 39 , 5, 26, 52, 71–82, 99, Locus coeruleus (LC), 23, 143, 144 105, 117, 204, 248, 251 Long-term care, 5, 12, 246, 255, 256 Obstructive sleep apnea syndrome (OSAS), 56, Loomis, Alfred Lee, 4, 21 84, 96, 105–109, 112, 204, 207–209, Loop gain, 54, 55 211, 212, 248, 251, 254, 256 292 Index

Older adults, 42–43, 121, 245–257 Rechtschaffen and Kales (R&K) system, 23, Optima moisture model, 7 24, 264 Orexin (hypocretin), 138, 142, 143 Relative humidity (RH), 7, 186 Oscillating behavior, 139 Relaxation training, 127, 128, 131, 177, 191 REM sleep. See Rapid eye movement (REM) sleep P Respiratory-event-related-arousal (RERA), 59, Paradoxical sleep, 23 264 , 36, 247, 253 Respiratory sinus arrhythmia (RSA), 173–177, Paraventricular hypothalamic nucleus (PVH), 179 141–143 Response surface analysis, 113 Pelvic muscle dysfunction biofeedback, 167 Restless legs syndrome (RLS), 25, 43, 248, Pervasive health care, 269–287 252–254, 256, 257 Phase-response curve (PRC), 142, 154 Retinal ganglion cells, 139, 140 Phase shift, 132, 138, 142–144, 146, 150 Retino-hypothalamic tract (RHT), 138, 140, Phase-shift hypothesis (PSH), 144 141 Phototherapy, 138, 144, 150 Retinorecipient structure, 140 Physiological response, 220 Pickwickian syndrome, 25, 262 Pieron,´ Henri, 20 S Pillar implants, 87, 99, 100 Seasonal affective disorder (SAD), 138, 139, Polarity, 169, 171 143, 144, 147, 150, 153 (PSG), 5–7, 19–30, 34, 35, Self-regulation skills, 176, 177 38, 39, 41, 43–45, 56, 59, 63–65, 75, 79, Sensorimotor rhythm (SMR), 171, 176–178 80, 82, 84, 106, 178, 201–206, 209, 220 Serotonergic (5-HT), 140, 144 Porter’s five forces, 278–280, 282, 284, 285 Shift work, 45, 138, 139, 143, 153, 154 Positional Therapy, 105–118 Shift work type, 153 Positron emission tomography (PET), 123, Short EEG arousal, 264 206–209 Sigma band, 171 Postpartum depression, 152 Single-photon emission computed tomography Preoptic nucleus, 138, 142, 143 (SPECT), 207, 209 Primary sleep disorder, 257 Skin conductance level (SCL), 196, 197 Progressive muscle relaxation (PMR), 128, Skin location, 223 131, 173, 174, 176, 191 Skin model, 223, 225–226 Proportional integrating measure (PIM), 38 Sleep apnea, 5, 26, 38, 52, 54, 56, 58, 60–61, Prostate-specific antigen (PSA), 213, 214 65, 71–83, 99, 105–109, 112, 113, 115, Pseudofeedback, 173 117, 204, 212, 248, 250–252, 264 Psychology, 12, 13, 33, 190, 266 Sleep Coach, 185–199, 282, 284 Sleep Coach-Doc, 191, 192, 194, 195 Sleep Coach for user, 191 Q Sleep dependency, 23 Quantitative actigraphic criteria (QAC), 39, 40 Sleep disordered breathing (SDB), 5, 26, 52, 54, 55, 58–60, 62–65, 105, 106, 112, 118, 187, 209, 264 R Sleep disorders, 5, 6, 12, 13, 19–30, 33–45, Radiofrequency, 5, 83, 95–99 51–65, 71–100, 105–118, 121–133, Ramon y Cajal, Santiago, 20 137–155, 167, 187, 192, 197, 199, 206, Rapid eye movement (REM), 22, 106, 205 209, 246–254, 263–265 Rapid eye movement (REM) sleep, 5, 9, 10, monitoring, 35 22, 23, 60, 77, 110, 186, 187, 205–207, Sleep efficiency (SE), 34, 39, 41, 42, 130, 132, 253, 262, 263 155, 192, 249 RBD, 253, 254, 256 Sleep environment, 4–8, 12, 13, 41, 185–199, Receiver operator characteristic (ROC), 40 253 Rechtschaffen, Allan, 5, 23, 264 Sleeper-centered , 185–199 Index 293

Sleep health care industry, 282 Total (TSD), 144, 145, 152, education, 128–129 153 Sleep medicine, 4, 5, 11, 13, 19–30, 58, 111, Total sleep time (TST), 34, 37, 39, 40, 42, 44, 154, 172, 173, 188, 197, 199, 246, 130, 132, 176, 178 261–267, 282, 284 Tracheostomy, 84, 89, 91 Sleep modeling, 6, 9–11 Tryptophan depletion, 144 latency (SOL), 26, 39–42, 132, Two-process model, 9 173, 174, 178, 210 Sleep restriction therapy, 130–131, 249 Sleep stage, 4, 5, 72, 109, 110, 186, 187 U Sleep treatment, 269–287 Ultraviolet light, 138, 148 Sleep-wake cycle, 138, 144, 154, 262 Upper airway resistance syndrome (UARS), Slow-wave activity (SWA), 9 26, 28, 54 Slow-wave sleep (SWS), 186 Uvulopalatopharyngoplasty (UPPP), 72, 85, 86 Small to middle sized enterprises (SMEs), 278 Stages of sleep, 4, 23, 59, 77, 82, 187, 209 Stimulus control therapy, 129–131 Subparaventricular zone (SPZ or sPVZ), 141, V 143 Vasoactive intestinal polypeptide (VIP), 140 Sullivan, Colin, 271, 272, 276 Ventrolateral (SCNvl), 140, 141 Suprachiasmatic nuclei (SCN), 138–143, 155, Ventrolateral preoptic nucleus (VLPO), 138, 186 142, 143 Surgical treatment, 83, 84 Vision-based driver fatigue, 220, 221 Vision system, 221, 240 Voltage, 169, 202 T Von Helmholtz, Hermann Ludwig Ferdinand, Tassinari, Carlo Alberto, 25 20 Technology management, 13 Voxel-based morphometry (VBM), 208, 209 Tennis ball technique, 114 Thanatos, 20 Thermal comfort model, 7 W Theta, 10–12, 171, 177, 178 Wake time after sleep onset (WASO), 34, 37, Three-dimensional activities, 43 39 3P Model, 124–126, 128 Wavelength, 27, 145, 148–149, 151, 186, 188 Three-process model, 9 Three types of apnoea: obstructive, central, and mixed, 25 Z Time above threshold (TAT), 38 Zeitgeber, 139, 152, 186 Total addressable market (TAM), 275 Zero-crossing mode (ZCM), 37, 38